Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.

Guests

  • Gardiner Harris science reporter for "The New York Times"
  • Rep. Rosa DeLauro U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of WorstPills.org

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

New Tactics In The Anti-Abortion Movement

Thursday, Aug 27 2015Abortion opponents seek details on women who get abortions and the doctors who perform them. Several states have moved to cut Planned Parenthood funding even for clinics without abortion services. Join us to discuss new tactics in the anti-abortion movement.